The monoclonal antibody teprotumumab has been shown to be effective in chronic thyroid eye disease, reducing double vision and proptosis.
Continue reading
Tag: clinical trial
Methylphenidate can improve visual field testing outcomes
Used for attention deficit-hyperactivity disorder (ADHD) and narcolepsy, the drug has also shown potential use in eliminating some cognitive artifacts
Continue reading
Corneal endothelial keratoplasty: DMEK vs UT-DSAEK
There were no differences between the two techniques in terms of best corrected visual acuity, refractive astigmatism, and endothelial cell
Continue reading
A conversation on conbercept, the new anti-VEGF in town
Conbercept has been shown in Phase III clinical studies to be safe and effective even with a quarterly dosing regimen
Continue reading
Pegcetacoplan: A new drug for geographic atrophy
This complement C3-inhibitor has passed phase 2 clinical studies in terms of safety and efficacy and is on track to
Continue reading